• SENSEX 73,895.74
    315.20 (+0.43%)
  • BANKNIFTY 55,580.40
    141.90 (+0.26%)
  • ICICI Bank
    1,311.70 1,187.55(%)
  • NSE
    1,790.00 1,790.00(%)
  • SS Retail
    692.30 603.00(%)
  • PB Fintech.
    1,115.10 1,115.10(%)
  • The Bombay Burmah
    1,425.75 1,301.00(%)
  • Hero Motors
    141.85 141.85(%)
  • Whirlpool India
    959.60 1,438.30(%)
  • Cholaman.Inv.&Fn
    1,638.05 1,299.80(%)
  • Larsen & Toubro
    3,885.90 4,440.00(%)
  • Tour. Fin. Corp.
    135.55 51.20(%)
  • Kotak Mah. Bank
    399.35 345.40(%)
  • AU Small Finance
    1,021.20 1,144.65(%)
  • Infosys
    991.75 984.00(%)
  • Rainbow Child.
    1,351.50 1,008.75(%)
  • Kaveri Seed Co.
    844.00 1,139.90(%)
  • Cupid
    274.15 298.95(%)
  • Reliance Industries
    1,227.20 1,611.20(%)
  • HDFC Bank
    739.50 1,020.35(%)
  • Shanti Gold
    333.00 333.00(%)
  • Tata Consumer
    979.10 979.10(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Senores Pharmaceuticals Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 93477.0
  • ISIN : INE0RB801010
1,355.20 11 (0.81%)
  • As on 25 Sep 2026 (EOD)

  • Today’s Low

    1,336.30

  • Today’s High

    1,394.40

  • Open

    1,344.30

  • Perv Close

    1,344.30

  • 52W Low

    662.45

  • 52W High

    1,599.00

Key Indicators

  • P/E(TTM)

    335.64

  • Mar.Cap (₹Cr.)

    6,241.18

  • Div & Yield %

    0.00

  • Book Value(₹)

    162.83

  • Debt-Equity Ratio

    0.81

  • AGM Date

    25-Sep-2026

  • EPS

    4.04

  • P/E Ratio

    335.64

Financials Ratios

  • Debt-Equity Ratio

    1.28

  • Mar.Cap (₹Cr.)

    6,241.18

  • RONW (%)

    26.19

  • ROCE (%)

    12.04

Score Board

  • Equity (₹ in Cr.)

    46.05

  • BV (₹)

    162.80

  • Sales( ₹ in Cr.)

    106.09

  • NP (in Cr.)

    20.25

  • NP Var(%)

    449.0

  • Div%

    0.0

  • CPS (₹)

    7.30

  • EPS (₹)

    4.40

  • Traded Value (₹ in Lakhs)

    6,244.87

  • 52 Week High

    1,599.00

  • 52 Week Low

    662.45

  • Price BSE

    1356.0

  • Price NSE

    1,355.00

  • Market Capital( in Cr.)

    6,244.87

  • P/C Ratio

    186.50

  • P/E Ratio

    308.40

  • Price Vs.BV

    4.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 38.54 34.01 12.38 13.54 7.91 -
Excise Duty 0.00 0.00 0.00 0.00 0.00 -
Net Sales 38.54 34.01 12.38 13.54 7.91 -
Other Income 21.99 6.84 6.79 0.94 0.15 -
Stock Adjustments 4.10 0.39 0.48 2.40 -0.05 -
Total Income 64.63 41.24 19.65 16.88 8.01 -
EXPENDITURE :            
Raw Materials 14.67 14.08 6.35 10.60 3.94 -
Power and Fuel Cost 0.44 0.31 0.00 0.00 0.03 -
Employee Cost 18.25 9.35 5.02 2.86 1.63 -
Other Manufacturing Expenses 9.32 6.89 0.05 0.04 0.76 -
Selling and Administration Expenses 7.19 3.79 2.96 1.28 0.35 -
Miscellaneous Expenses 0.05 0.04 0.26 0.00 0.14 -
Employee Benefit Expenses 18.25 9.35 5.02 2.86 1.63 -
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 -
Total Expenses 49.92 34.46 14.65 14.79 6.84 -
Operating Profit 14.71 6.78 5.01 2.10 1.17 -
Interest 6.52 2.71 2.14 0.56 0.20 -
Gross Profit 8.19 4.07 2.87 1.54 0.97 -
Depreciation 3.08 2.04 0.93 0.71 0.57 -
Profit Before Tax 5.11 2.03 1.94 0.83 0.40 -
Current Tax 1.45 1.36 0.35 0.17 0.01 -
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 -
Deferred Tax -0.03 -0.14 0.39 -0.02 -0.45 -
Reported Net Profit 3.69 0.81 1.20 0.68 0.84 -
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 -
Adjusted Net Profit 3.69 0.81 1.20 0.68 0.84 -
Adjustment below Net Profit 0.01 0.01 0.00 0.00 0.00 -
P & L Balance brought forward 3.39 2.57 1.37 0.69 0.34 -
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 -
Appropriations 0.00 0.00 0.00 0.00 0.00 -
P & L Balance carried down 7.09 3.39 2.57 1.37 1.18 -
Dividend 0.00 0.00 0.00 0.00 0.00 -
Preference Dividend 0.00 0.00 0.00 0.00 0.00 -
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 -
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 -
Earnings Per Share-Unit Curr 0.80 0.27 1.22 0.78 2.20 -
Earnings Per Share(Adj)-Unit Curr 0.80 - - - - -
Book Value 153.74 55.10 39.66 38.54 24.91 -
Book Value(Adj)-Unit Curr 153.74 - - - - -

Shareholding Pattern

  • Promoter Group

    45.82%

  • Public Share Holding

    54.18%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 312,689 312,689.00 312,689 312,689
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 2,892,629 6.28 2,892,629 3
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 6,475,463 14.06 6,475,463 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 11,732,265 25.48 11,732,265 10
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 18,207,728 39.54 18,207,728 13
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 3,047,954 6.62 3,047,954 37
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 746,252 1.62 746,252 1
Mutual Funds / UTI 3,019,755 6.56 3,019,755 7
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 733,555 1.59 733,555 20
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 7,547,516 16.39 7,547,516 65
2] Non Institution
Bodies Corporate 1,912,091 4.15 1,912,091 274
Clearing Members 51,309 0.11 51,309 23
Directors of their Relatives 20,000 0.04 20,000 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 404,335 0.88 404,335 663
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,130,480 2.45 1,130,480 982
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 6,343,732 13.77 6,343,732 61
Individuals holding nominal share capital up to Rs. 1 lakh 7,125,204 15.47 7,125,204 34,360
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 532 0.00 532 1
Others 200,000 0.43 200,000 1
Sub Total 17,405,715 37.79 17,405,715 36,417
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 46,053,588 100.00 46,053,588 36,498

Company Background

Senores Pharmaceuticals LtdPharmaceuticals - Indian - Formulations

  • Senores Pharmaceuticals Ltd
  • BSE Code : 93477.0
  • ISIN : INE0RB801010

  • Incorporation Year

    2017

  • Registered Office

    #.1101-1103 11th Flr South Twr
    Ambali Bopal Road, Ahmedabad,
    Gujarat-380054

  • Telephone

    +91-79-2999 9857

  • FAX

  • Chairman

    Sanjay Majmudar

  • Managing Director

    SWAPNIL JATINBHAI SHAH

  • Company Secretary

  • Auditor

    Pankaj R Shah & Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Senores Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Senores Pharma. 1,356.00 60.53 38.54 335.64 2.15
Abbott India 26,935.80 7,217.19 6,929.05 35.45 43.78
Astrazeneca Phar 6,517.85 2,304.07 2,275.58 96.06 27.86
Glaxosmi. Pharma 2,816.85 3,932.76 3,790.20 45.00 58.17
Novartis India 1,961.40 393.10 354.33 49.53 15.94
Cipla 1,397.20 20,102.60 18,979.95 36.72 13.88
Bliss GVS Pharma 709.30 773.53 729.81 65.92 12.51
Amrutanjan Healt 506.15 520.13 502.55 27.11 24.16
Fermenta Biotec. 468.15 474.15 450.25 21.86 18.77
Guj. Themis Bio. 417.30 168.25 165.82 111.58 18.05
Ambalal Sarabhai 40.55 19.52 3.94 75.09 6.77